Purified by proprietary chromatographic technique.
Dengue virus (DENV) is a mosquito-borne virus that infects millions of people annually across more than 120 countries . The virus is classified into four distinct serotypes: DENV-1, DENV-2, DENV-3, and DENV-4. Each serotype can cause dengue fever, which can escalate into severe dengue, leading to hemorrhagic fever and potentially fatal outcomes .
The dengue virus is an RNA virus belonging to the Flaviviridae family. The viral genome encodes three structural proteins: the capsid ©, membrane (M), and envelope (E) proteins, along with seven non-structural proteins . The envelope protein (E) is crucial for virus entry into host cells and is a primary target for neutralizing antibodies .
DENV-4 is one of the four serotypes of the dengue virus. It shares many structural similarities with the other serotypes but has unique antigenic properties that distinguish it from the others . The envelope protein of DENV-4 plays a significant role in the virus’s ability to infect host cells and elicit an immune response.
The recombinant envelope protein of DENV-4, specifically the 22kDa fragment, is a genetically engineered peptide derived from the envelope protein of the virus . This recombinant protein is often produced in E. coli and includes a 6xHis tag for purification purposes . The 22kDa fragment contains epitopes that are recognized by the immune system, making it a valuable tool for research and vaccine development.